PGLYRP2 and glaucoma: In PACG, inflammation-related proteins and pathways are upregulated. SPP1 promotes the secretion of inflammatory factors such as IL-6 and TNF-α, while PGLYRP2 induces the production of IL-1 and IL-6, participating in the inflammatory response in glaucoma.